{"id":"https://openalex.org/W3211004259","doi":null,"title":"Advances in Drug Design","display_name":"Advances in Drug Design","alternate_titles":[],"publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3211004259","mag":"3211004259"},"language":"en","primary_location":{"id":"mag:3211004259","doi":null,"is_oa":false,"landing_page_url":"https://www.scirp.org/book/detailedinforofabook.aspx?bookid=2792","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W3211004259"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004957941","display_name":"Varnavas D. Mouchlis","orcid":"https://orcid.org/0000-0002-4235-1867","observed_orcids":["https://orcid.org/0000-0002-4235-1867"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Varnavas D. Mouchlis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041632230","display_name":"Angela Serra","orcid":"https://orcid.org/0000-0002-3374-1492","observed_orcids":["https://orcid.org/0000-0002-3374-1492"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Angela Serra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029916489","display_name":"Eugene N. Muratov","orcid":"https://orcid.org/0000-0003-4616-7036","observed_orcids":["https://orcid.org/0000-0003-4616-7036"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eugene Muratov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028024531","display_name":"Marilia Nn Lima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marilia Nn Lima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5040253164","display_name":"Wesley H. Brooks","orcid":"https://orcid.org/0000-0002-5604-3769","observed_orcids":["https://orcid.org/0000-0002-5604-3769"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wesley H. Brooks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1404,"has_fulltext":false,"cited_by_count":4,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.29115681,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10044","display_name":"Protein Structure and Dynamics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.9750000238418579},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.8619999885559082},{"id":"https://openalex.org/keywords/computer-aided-drug-design","display_name":"computer-aided drug design","score":0.9990000128746033},{"id":"https://openalex.org/keywords/protein-ligand-binding","display_name":"protein-ligand binding","score":0.8320000171661377},{"id":"https://openalex.org/keywords/small-molecule-drugs","display_name":"small molecule drugs","score":0.5979999899864197},{"id":"https://openalex.org/keywords/biopharmaceuticals","display_name":"biopharmaceuticals","score":0.8870000243186951},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.9769999980926514},{"id":"https://openalex.org/keywords/therapeutic-peptides","display_name":"peptide therapeutics","score":0.8740000128746033},{"id":"https://openalex.org/keywords/protein-stability","display_name":"protein stability","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C192071366","wikidata":"https://www.wikidata.org/wiki/Q2991682","display_name":"Drug design","level":2,"score":0.8292464017868042},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.7806136608123779},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7461209297180176},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5347633957862854},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.46847859025001526},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3208487629890442},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24368759989738464},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24062210321426392},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2019250988960266},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13973557949066162},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.10834354162216187}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3211004259","doi":null,"is_oa":false,"landing_page_url":"https://www.scirp.org/book/detailedinforofabook.aspx?bookid=2792","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2258123653","https://openalex.org/W1495033921","https://openalex.org/W2554444907","https://openalex.org/W4404905923","https://openalex.org/W7202148642","https://openalex.org/W4400123947","https://openalex.org/W3190671332","https://openalex.org/W4400922546","https://openalex.org/W2566855725","https://openalex.org/W2882997555"],"abstract_inverted_index":{"Drug":[0,95],"design,":[1,12],"often":[2],"referred":[3,112],"to":[4,59,81,93,113,142],"as":[5,48,114,136],"rational":[6,11],"drug":[7,30,67,116,119,138],"design":[8,68,71,96,120],"or":[9,40],"simply":[10],"is":[13,31,110,134],"the":[14,23,42,60,63,70,82,124,127,131,164],"inventive":[15],"process":[16],"of":[17,25,44,72,108,126,130,157,169],"finding":[18],"new":[19],"medications":[20],"based":[21],"on":[22,102,123],"knowledge":[24,125],"a":[26,45,49,56],"biological":[27],"target.":[28],"The":[29],"most":[32,64],"commonly":[33],"an":[34,153],"organic":[35],"small":[36,143],"molecule":[37],"that":[38,74,121],"activates":[39],"inhibits":[41],"function":[43],"biomolecule":[46],"such":[47],"protein,":[50],"which":[51,86],"in":[52,55,77],"turn":[53],"results":[54],"therapeutic":[57,150],"benefit":[58],"patient.":[61],"In":[62,140],"basic":[65],"sense,":[66],"involves":[69],"molecules":[73],"are":[75,152],"complementary":[76],"shape":[78],"and":[79,89,148,159,167],"charge":[80],"biomolecular":[83,132],"target":[84,133],"with":[85],"they":[87],"interact":[88],"therefore":[90],"will":[91],"bind":[92],"it.":[94],"frequently":[97],"but":[98],"not":[99],"necessarily":[100],"relies":[101,122],"computer":[103],"modeling":[104,109],"techniques.":[105],"This":[106],"type":[107],"sometimes":[111],"computer-aided":[115],"design.":[117,139],"Finally,":[118],"three-dimensional":[128],"structure":[129],"known":[135],"structure-based":[137],"addition":[141],"molecules,":[144],"biopharmaceuticals":[145],"including":[146],"peptides":[147],"especially":[149],"antibodies":[151],"increasingly":[154],"important":[155],"class":[156],"drugs":[158],"computational":[160],"methods":[161],"for":[162],"improving":[163],"affinity,":[165],"selectivity,":[166],"stability":[168],"these":[170],"protein-based":[171],"therapeutics":[172],"have":[173],"also":[174],"been":[175],"developed.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3211004259","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2021-11-08T00:00:00"}
